Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/92689
PIRA download icon_1.1View/Download Full Text
Title: Delay of cone degeneration in retinitis pigmentosa using a 12-month treatment with Lycium barbarum supplement
Authors: Chan, HHL 
Lam, HI 
Choi, KY 
Li, SZC 
Lakshmanan, Y 
Yu, WY 
Chang, RCC
Lai, JSM
So, KF
Issue Date: 23-May-2019
Source: Journal of ethnopharmacology, 23 May 2019, v. 236, p. 336-344
Abstract: Ethnopharmacological relevance: Lycium barbarum L. (also known as “Goji berry”), a traditional Chinese herbal medicine, has been a common herb in the traditional Chinese pharmacopoeia for centuries. The main active component is the Lycium barbarum polysaccharides and its antioxidative effect has been widely shown to provide neuroprotection to the eye, and it would, therefore, be interesting to determine if Lycium barbarum help delay vision deterioration in patients with retinitis pigmentosa.
Aim of the study: Cone rescue is a potential method for delaying deterioration of visual function in Retinitis pigmentosa (RP). This study aimed to investigate the treatment effect of Lycium barbarum L. (LB) supplement on retinal functions and structure in RP patients after a 12-month intervention trial.
Methods: The investigation was a double-masked and placebo-controlled clinical study. Each of forty-two RP subjects who completed the 12-month intervention (23 and 19 in the treatment and placebo groups respectively) received a daily supply of LB or placebo granules for oral administration. The primary outcome was change of best corrected visual acuity (VA) (90% and 10% contrast) from the baseline to the end of treatment. The secondary outcomes were sensitivity changes of the central visual field, amplitude of full-field electroretinogram (ffERG) (including scotopic maximal response and photopic cone response), and average macular thickness.
Results: The compliance rates for both groups exceeded 80%. There were no deteriorations of either 90% or 10% contrast VA in the LB group compared with the placebo group (p = 0.001). A thinning of macular layer was observed in the placebo group, which was not observed in the LB group (p = 0.008). However, no significant differences were found in the sensitivity of visual field or in any parameters of ffERG between the two groups. No significant adverse effects were reported in the treatment group.
Conclusions: LB supplement provides a neuroprotective effect for the retina and could help delay or minimize cone degeneration in RP.
Keywords: Antioxidant (2.084)
Clinical trial (2.172)
Lycium barbarum
Neuroprotection
Retinal degeneration
Retinitis pigmentosa
Traditional Chinese medicine (2.592)
Publisher: Elsevier
Journal: Journal of ethnopharmacology 
ISSN: 0378-8741
EISSN: 1872-7573
DOI: 10.1016/j.jep.2019.03.023
Rights: © 2019 Elsevier B.V. All rights reserved.
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
The following publication Chan, H. H. L., Lam, H. I., Choi, K. Y., Li, S. Z. C., Lakshmanan, Y., Yu, W. Y., ... & So, K. F. (2019). Delay of cone degeneration in retinitis pigmentosa using a 12-month treatment with Lycium barbarum supplement. Journal of ethnopharmacology, 236, 336-344 is available at https://doi.org/10.1016/j.jep.2019.03.023
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
Chan_Delay_Cone_Degeneration.pdfPre-Published version1.33 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Final Accepted Manuscript
Access
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

60
Last Week
0
Last month
Citations as of May 5, 2024

Downloads

181
Citations as of May 5, 2024

SCOPUSTM   
Citations

34
Citations as of May 3, 2024

WEB OF SCIENCETM
Citations

31
Citations as of May 2, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.